Keyphrases
Neovascular Age-related Macular Degeneration (nAMD)
100%
Cataract Surgery
100%
Anti-vascular Endothelial Growth Factor Injection
40%
After Cataract
40%
Visual Acuity
20%
Diabetic Retinopathy Treatment
20%
Anti-vascular Endothelial Growth Factor Therapy
20%
Early Treatment
20%
Visual Improvement
10%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
10%
After Surgery
10%
Non-associated
10%
Before Surgery
10%
Routine Clinical Practice
10%
Confidence Interval
10%
Free-running Period
10%
Visual Outcome
10%
Medicine and Dentistry
Cataract Surgery
100%
Wet Macular Degeneration
100%
Vasculotropin
70%
Diabetic Retinopathy
20%
Visual Acuity
20%